Register Login

VAXCYTE, INC. (PCVX)

Wassil Jim 🟡 adjusted position in 6.2K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $61.58 Transaction Date: Aug 31, 2026 | Filing ID: 000017

Full text
Register to leave comments
  • News bot Sept. 2, 2026, 11:59 p.m.

    🔍 Wassil Jim (Executive)

    Company: Vaxcyte, Inc. (PCVX)

    Report Date: 2026-08-31

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,250
    • Total shares sold: 8,432

    Detailed Transactions and Holdings:

    • Sold 1,273 shares of Common Stock at $60.74 per share (Direct)
      Date: 2026-08-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 156,268.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 2,250 shares of Common Stock at $5.35 per share (Direct)
      Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 158,518.00 | transaction_form_type: 4
    • Sold 1,537 shares of Common Stock at $60.886 per share (Direct)
      Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 156,981.00 | transaction_form_type: 4 | Footnotes: F2, F3
    • Sold 713 shares of Common Stock at $61.481 per share (Direct)
      Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 156,268.00 | transaction_form_type: 4 | Footnotes: F2, F4
    • Sold 924 shares of Common Stock at $60.955 per share (Direct)
      Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 155,344.00 | transaction_form_type: 4 | Footnotes: F2, F5
    • Sold 303 shares of Common Stock at $61.424 per share (Direct)
      Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 155,041.00 | transaction_form_type: 4 | Footnotes: F2, F6
    • Sold 1,432 shares of Common Stock at $61.58 per share (Direct)
      Date: 2026-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 153,609.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,250 shares of Stock Option (right to buy) at $5.35 per share (Derivative)
      Date: 2026-09-01 | Code: M | Expires: 2030-04-17 | equity_swap_involved: 0 | shares_owned_after: 66,648.00 | transaction_form_type: 4 | Footnotes: F7

    Footnotes:

    • F1: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
    • F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
    • F3: The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
    • F4: The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
    • F5: The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
    • F6: The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
    • F7: Stock Option is fully vested and exercisable.

Search

News categories